Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Source: Senate LDA
| GREATER NEW YORK HOSPITAL ASSOCIATION |
| 30 |
| 2011–2018 |
| DEXCOM INC | 27 | 2018–2023 |
| AMERICAN ASSOCIATION OF NURSE ANESTHETISTS | 26 | 2011–2017 |
| HOLOGIC, INC. | 22 | 2016–2025 |
| CELGENE CORPORATION | 16 | 2011–2015 |
| AMERICAN HEALTH QUALITY ASSOCIATION | 14 | 2011–2014 |
| HEALTH MANAGEMENT ASSOCIATES | 10 | 2011–2014 |
| BIOMERIEUX, INC. | 7 | 2025–2026 |
| ATHENAHEALTH | 6 | 2011–2012 |
| VITAS INNOVATIVE HOSPICE CARE | 6 | 2013–2014 |
| CETERO RESEARCH | 5 | 2011–2012 |
| AGENDIA, INC. | 4 | 2025–2026 |
| CERVIVOR | 3 | 2018 |
| CONTINUA HEALTH ALLIANCE | 3 | 2011 |
| NAVICENT HEALTH | 3 | 2016–2017 |
| HEALTHTRACKRX | 2 | 2025 |
| TEMPUS LABS INC | 2 | 2023 |
| UNITED HEALTH SERVICES - PRUITT CORPORATION | 2 | 2015 |
| BALL JANIK LLP (ON BEHALF OF THE STATE OF OREGON) | 1 | 2011 |
| BNN HOLDINGS CORP | 1 | 2013 |
| DIABETES TECHNOLOGY ACCESS COALITION (INFORMAL COALITION) | 1 | 2022 |
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Payment and regulation of clinical laboratory tests. H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Patients Deserve Price Tags Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
S.2355, Patients Deserve Price Tags Act. Prior Authorization.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Payment and regulation of clinical laboratory tests. H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Saving Access to Laboratory Services Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
Payment and regulation of clinical laboratory testing. H.R.8188/S.4449, Saving Access to Laboratory Services Act.
Saving Access to Laboratory Services Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
Payment and regulation of clinical laboratory testing. H.R.8188/S.4449, Saving Access to Laboratory Services Act.
Saving Access to Laboratory Services Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
Payment and regulation of clinical laboratory testing. H.R.8188/S.4449, Saving Access to Laboratory Services Act.
Saving Access to Laboratory Services Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: ALSTON & BIRD LLP
Payment and regulation of clinical laboratory testing. H.R.8188/S.4449, Saving Access to Laboratory Services Act.
Give Kids a Chance Act
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Give Kids a Chance Act
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Give Kids a Chance Act
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Give Kids a Chance Act
Client: ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Firm: ALSTON & BIRD LLP
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases; Medication affordability and access.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases; Medication affordability and access.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
Issues related to the scoring of Preventive Health Savings Act, H.R. 2584/S. 1361.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
General diabetes prevention; medication affordability and access; S. 1948/H.R. 3709, Chronic Disease Management Act; issues related to high deductible health plan pre-deductible coverage of treatments and services for chronic diseases.
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEATHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEATHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEATHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
Medicare Orthotics and Prosthetics Improvement Act of 2017
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION (AOPA) · Firm: ALSTON & BIRD LLP
H.R. 2599/S. 1191 The Medicare Orthotics and Prosthetics Improvement Act of 2017; Orthotics and prosthetic parity; Medicare reimbursement; Medicare local coverage determination.
Medicare Orthotics and Prosthetics Improvement Act of 2017
Client: AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION (AOPA) · Firm: ALSTON & BIRD LLP
H.R. 2599/S. 1191 The Medicare Orthotics and Prosthetics Improvement Act of 2017; Orthotics and prosthetic parity; Medicare reimbursement; Medicare local coverage determination.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R.2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations).
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R.2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations), and FY19 Labor, Health and Human Services, and Education Appropriations.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R. 2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations), and FY19 Labor, Health and Human Services, and Education Appropriations.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R.2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations).
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R.2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations), and FY19 Labor, Health and Human Services, and Education Appropriations.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R.2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations).
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: ALSTON & BIRD LLP
H.R. 2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations), and FY19 Labor, Health and Human Services, and Education Appropriations.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
S.2355, Patients Deserve Price Tags Act. Prior Authorization.
Payment and regulation of clinical laboratory tests. H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Medicare coverage.
Issues related to Medicare coverage.
AGENDIA, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · RR
Issues related to Medicare coverage.
Issues related to Medicare coverage.
HOLOGIC, INC. via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues related to global women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Reforming technical certification of in vitro diagnostic tests.
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2025 · third_quarter · Q3
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).
HEALTHTRACKRX via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Medicare and Medicaid laboratory reimbursement issues.
Medicare and Medicaid laboratory reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2025 · second_quarter · Q2
Payment and regulation of clinical laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2025 · second_quarter · RR
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
HEALTHTRACKRX via ALSTON & BIRD LLP
2025 · second_quarter · RR
Medicare and Medicaid laboratory reimbursement issues.
Medicare and Medicaid laboratory reimbursement issues.
HOLOGIC, INC. via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2024 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing. H.R.8188/S.4449, Saving Access to Laboratory Services Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2024 · third_quarter · Q3
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health, and medical device issues, including right to repair and AI.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2024 · third_quarter · Q3
Payment and regulation of clinical laboratory testing. H.R.8188/S.4449, Saving Access to Laboratory Services Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2024 · second_quarter · Q2
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2024 · second_quarter · Q2
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2024 · second_quarter · Q2
Payment and regulation of clinical laboratory testing; pandemic preparedness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2024 · first_quarter · Q1
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2024 · first_quarter · Q1
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2024 · first_quarter · Q1
Payment and regulation of clinical laboratory testing; pandemic preparedness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
TEMPUS LABS, INC. via ALSTON & BIRD LLP
2023 · fourth_quarter · 4T
Medicare reimbursement for clinical laboratory tests. Support for access to precision medicine.
Medicare reimbursement for clinical laboratory tests. Support for access to precision medicine.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2023 · fourth_quarter · 4T
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
Issues related to women's health, including prevention, diagnostics and imaging. Issues related to breast and cervical health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2023 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing; pandemic preparedness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
TEMPUS LABS, INC. via ALSTON & BIRD LLP
2023 · fourth_quarter · RR
Medicare reimbursement for clinical laboratory tests. Support for access to precision medicine.
Medicare reimbursement for clinical laboratory tests. Support for access to precision medicine.
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2023 · third_quarter · Q3
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2023 · third_quarter · Q3
Payment and regulation of clinical laboratory testing; pandemic preparedness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2023 · third_quarter · Q3
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2023 · third_quarter · Q3
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2023 · second_quarter · Q2
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2023 · second_quarter · Q2
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2023 · second_quarter · Q2
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2023 · second_quarter · Q2
Payment and regulation of clinical laboratory testing; pandemic preparedness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2023 · first_quarter · Q1
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2023 · first_quarter · Q1
Payment and regulation of clinical laboratory testing; pandemic preparedness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2023 · first_quarter · Q1
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2023 · first_quarter · Q1
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health and issues related to COVID-19 diagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2023 · first_quarter · Q1
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2022 · fourth_quarter · Q4
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2022 · fourth_quarter · Q4
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2022 · fourth_quarter · Q4
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health and issues related to COVID-19 diagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2022 · fourth_quarter · Q4
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2022 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2022 · third_quarter · Q3
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2022 · third_quarter · Q3
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2022 · third_quarter · Q3
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health and issues related to COVID-19 diagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2022 · third_quarter · Q3
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2022 · third_quarter · Q3
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2022 · second_quarter · Q2
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2022 · second_quarter · Q2
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2022 · second_quarter · Q2
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health and issues related to COVID-19 diagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2022 · second_quarter · Q2
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2022 · second_quarter · Q2
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DIABETES TECHNOLOGY ACCESS COALITION (INFORMAL COALITION) via ALSTON & BIRD LLP
2022 · second_quarter · RR
Issues related to access to diabetes technology
Issues related to access to diabetes technology
DEXCOM, INC. via ALSTON & BIRD LLP
2022 · first_quarter · Q1
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2022 · first_quarter · Q1
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP); H.R. 5416, Give Kids a Chance Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOLOGIC, INC. via ALSTON & BIRD LLP
2022 · first_quarter · Q1
Issues related to women's health, including prevention, diagnostics and imaging; Issues related to breast and cervical health and issues related to COVID-19 diagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2022 · first_quarter · Q1
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2022 · first_quarter · Q1
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2021 · fourth_quarter · Q4
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2021 · fourth_quarter · Q4
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2021 · fourth_quarter · Q4
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2021 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2021 · third_quarter · Q3
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2021 · third_quarter · Q3
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2021 · third_quarter · Q3
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2021 · third_quarter · Q3
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2021 · second_quarter · Q2
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2021 · second_quarter · Q2
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2021 · second_quarter · Q2
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2021 · second_quarter · Q2
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2021 · first_quarter · Q1
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2021 · first_quarter · Q1
Medicaid and Children's Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2021 · first_quarter · Q1
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2021 · first_quarter · Q1
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2020 · fourth_quarter · Q4
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2020 · fourth_quarter · Q4
Medicaid and Childrens Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2020 · fourth_quarter · Q4
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2020 · fourth_quarter · Q4
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2020 · third_quarter · Q3
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2020 · third_quarter · Q3
Medicaid and Childrens Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2020 · third_quarter · Q3
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via ALSTON & BIRD LLP
2020 · third_quarter · Q3
Payment and regulation of clinical laboratory testing; coverage, payment, and government funding for public health-related testing for COVID-19.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2020 · first_quarter · 1A
Issues related to coverage and reimbursement for continuous glucose monitor.
Issues related to coverage and reimbursement for continuous glucose monitor.
DEXCOM, INC. via ALSTON & BIRD LLP
2020 · second_quarter · 2A
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Issues related to coverage and reimbursement for continuous glucose monitor; issues relating to the impact of the COVID-19 emergency.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DEXCOM, INC. via ALSTON & BIRD LLP
2020 · second_quarter · Q2
Issues related to coverage and reimbursement for continuous glucose monitor.
Issues related to coverage and reimbursement for continuous glucose monitor.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ST. JUDE CHILDREN'S RESEARCH HOSPITAL via ALSTON & BIRD LLP
2020 · second_quarter · Q2
Issues related to Medicaid; Public Readiness and Emergency Preparedness Act (PREP).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS via ALSTON & BIRD LLP
2020 · second_quarter · Q2
Medicaid and Childrens Health Insurance Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.